Medical robotics

ReWalk Announces Binding Offer to Deutsche Gesetzliche Unfallversicherung (DGUV) - German Social Accident Insurance

Retrieved on: 
Tuesday, May 12, 2020
Assistive technology, Robotics, Technology, Articles, ReWalk, Medical robotics, Prosthetics, Powered exoskeleton

and YOKNEAM ILIT, Israel and BERLIN, May 12, 2020 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical devices for individuals with lower limb disabilities, announced the acceptance of the binding offer by DGUV (Deutsche Gesetzliche Unfallversicherung / The German Social Accident Insurance) to provide qualified spinal cord injury (SCI) patients with the ReWalk 6.0 robotic exoskeleton device.

Key Points: 
  • and YOKNEAM ILIT, Israel and BERLIN, May 12, 2020 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical devices for individuals with lower limb disabilities, announced the acceptance of the binding offer by DGUV (Deutsche Gesetzliche Unfallversicherung / The German Social Accident Insurance) to provide qualified spinal cord injury (SCI) patients with the ReWalk 6.0 robotic exoskeleton device.
  • This binding offer applies for the provision of ReWalk Exoskeletons for all insured persons of the 36 different DGUV members/insurances.
  • Qualified SCI patients who are beneficiaries of DGUV have the opportunity to be supplied with a ReWalk 6.0 exoskeleton for home and community use.
  • "Germany's health care system is a world leader in establishing new standards of care for their population," said Larry Jasinski, CEO of ReWalk.

ReWalk Enters Agreements with Leading German Insurers TK and DAK-Gesundheit to Provide Coverage of Robotic Exoskeletons for Individuals with Spinal Cord Injuries

Retrieved on: 
Thursday, April 23, 2020
Assistive technology, Robotics, Technology, Articles, Medical robotics, Prosthetics, ReWalk, Powered exoskeleton, Spinal cord

These new policies will allow any eligible beneficiary with a spinal cord injury ("SCI") to seek procurement of a ReWalk 6.0 exoskeleton system.

Key Points: 
  • These new policies will allow any eligible beneficiary with a spinal cord injury ("SCI") to seek procurement of a ReWalk 6.0 exoskeleton system.
  • "The agreements with TK and DAK are monumental for national procurement policies for exoskeletons, both in Germany and worldwide," said ReWalk CEO Larry Jasinski.
  • "The advantages of this highly innovative supply have convinced us," said Mr. Thomas Bodmer, Board Member at DAK-Gesundheit.
  • ReWalk Robotics Ltd.develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.

Ekso Bionics® to Report First Quarter 2020 Financial Results on April 30, 2020

Retrieved on: 
Thursday, April 23, 2020
Ekso Bionics, Articles, Contents, Life sciences, Bionics, Assistive technology, Medical robotics

RICHMOND, Calif., April 23, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the first quarter 2020 after the close of trading on Thursday, April 30, 2020.

Key Points: 
  • RICHMOND, Calif., April 23, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the first quarter 2020 after the close of trading on Thursday, April 30, 2020.
  • ET to discuss the financial results and recent business developments.
  • Ekso Bionics is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications.
  • The Company is headquartered in the Bay Area and is listed on the Nasdaq Capital Market under the symbol EKSO.

The Weight Is Over: HeroWear, LLC Launches Exoskeleton Technology For All

Retrieved on: 
Tuesday, March 31, 2020
Robotics, Medical robotics, Prosthetics, Powered exoskeleton, Technology

NASHVILLE, Tenn., March 31, 2020 /PRNewswire/ -- HeroWear LLC has launched their revolutionary exosuit today as part of the WeaRAcon 2020 virtual conference.

Key Points: 
  • NASHVILLE, Tenn., March 31, 2020 /PRNewswire/ -- HeroWear LLC has launched their revolutionary exosuit today as part of the WeaRAcon 2020 virtual conference.
  • Designed to fit both men and women, the Apex is a back-assist exoskeleton device that reduces strain on the lower back for benders, lifters and leaners.
  • Researched, developed, and tested at Vanderbilt University, HeroWear's non-powered tech combines robust strength and ease of use.
  • "We believe that many hardworking people of the world could benefit from the power of exoskeleton or exosuit technologies," says CEO and cofounder Mark Harris.

ReWalk Announces Progress with German Statutory Health Insurer to Provide Coverage of Robotic Exoskeletons for Individuals With Spinal Cord Injuries

Retrieved on: 
Wednesday, March 18, 2020
Assistive technology, Robotics, Technology, Articles, ReWalk, Medical robotics, Powered exoskeleton

This agreement, the first in a series of anticipated national policies from German insurers, is expected to have a significant impact for spinal cord injured individuals.

Key Points: 
  • This agreement, the first in a series of anticipated national policies from German insurers, is expected to have a significant impact for spinal cord injured individuals.
  • That addition was a critical turning point, enabling any of Germany's 105 SHIs to pursue national policies for ReWalk procurement.
  • "This is the first in a series of contracts with German insurers that will benefit paralyzed individuals nationwide.
  • ReWalk Robotics Ltd.develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.

Join WearRA, ASTM and ASU for Robotics Week

Retrieved on: 
Thursday, February 27, 2020
Robotics, Medical robotics, Industrial robotics, Body armor, Powered exoskeleton

Immediately following WearRAcon, ASTM Committee F48 Exoskeletons and Exosuits will host their biannual meeting, and to round out the week ASU will host the Southwest Robotics Symposium.

Key Points: 
  • Immediately following WearRAcon, ASTM Committee F48 Exoskeletons and Exosuits will host their biannual meeting, and to round out the week ASU will host the Southwest Robotics Symposium.
  • "We are excited to collaborate with ASTM and ASU to bring a full week of robotics education and events to Arizona," said Joseph Hitt, Ph.D., Co-Founder and Executive Director of the Wearable Robotics Association .
  • "These events bring together wearable robotics professionals and entrepreneurs from industry, medical/rehab, academia, and government all in one place."
  • ASU Southwest Robotics Symposium | April 2-3:
    The ASU Southwest Robotics Symposium will focus on three themes this year: Manufacturing and Robotics, Agriculture and Robotics, and Mobility and Robotics.

Ekso Bionics® Announces Collaboration with Kindred Healthcare to Pilot EksoNR in Long-Term Acute Care Hospitals

Retrieved on: 
Tuesday, February 25, 2020
Articles, Health, Robotics, Ekso Bionics, Kindred Healthcare, Medical robotics, Assistive technology, Powered exoskeleton, Rehabilitation hospital, Acute care, Kindred, Hospital

RICHMOND, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced a collaboration with Kindred Healthcare, LLC ("Kindred") to pilot EksoNR the most clinically used robotic exoskeleton, in their long-term acute care hospitals.

Key Points: 
  • RICHMOND, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced a collaboration with Kindred Healthcare, LLC ("Kindred") to pilot EksoNR the most clinically used robotic exoskeleton, in their long-term acute care hospitals.
  • Kindred already offers exoskeleton-assisted rehabilitation with the device in over 20 of its freestanding inpatient Kindred rehabilitation hospitals.
  • Kindred is the first network to explore the benefits of EksoNR in the long-term acute care setting.
  • The pilot began last year and is now being conducted in four of Kindreds long-term acute care hospitals in the Houston-metro area.

Ekso Bionics® to Report Fourth Quarter and Full Year 2019 Financial Results on February 27, 2020

Retrieved on: 
Thursday, February 20, 2020
Ekso Bionics, Articles, Contents, Life sciences, Bionics, Assistive technology, Medical robotics

RICHMOND, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the fourth quarter and full year 2019 after the close of trading on Thursday, February 27, 2020.

Key Points: 
  • RICHMOND, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the fourth quarter and full year 2019 after the close of trading on Thursday, February 27, 2020.
  • ET to discuss the financial results and recent business developments.
  • Ekso Bionics is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications.
  • The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol EKSO.

Post Acute Medical (PAM) Accelerates Adoption of Exoskeleton Rehabilitation with Three Additional EksoNR Devices from Ekso Bionics®

Retrieved on: 
Wednesday, February 19, 2020
Articles, Health, Ekso Bionics, Rehabilitation hospital, Hospital, Assistive technology, Medical robotics

and RICHMOND, Calif., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Post Acute Medical, LLC, (PAM), a system of inpatient rehabilitation hospitals, has acquired three additional EksoNR devices from Ekso Bionics (Nasdaq: EKSO) to expand the availability of exoskeleton-assisted rehabilitation to seven of its facilities.

Key Points: 
  • and RICHMOND, Calif., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Post Acute Medical, LLC, (PAM), a system of inpatient rehabilitation hospitals, has acquired three additional EksoNR devices from Ekso Bionics (Nasdaq: EKSO) to expand the availability of exoskeleton-assisted rehabilitation to seven of its facilities.
  • The device is designed to help patients stand and walk during rehabilitation after a stroke or spinal cord injury.
  • We are pleased to respond to the needs of our patients and providers with three additional EksoNR devices.
  • Inpatient rehabilitation hospitals are specialty hospitals or parts of acute care hospitals that offer intensive rehabilitation therapy.

ReWalk Robotics to Report Fourth Quarter and Year-End 2019 Financial Results on February 20, 2020

Retrieved on: 
Monday, February 17, 2020
Assistive technology, Technology, Articles, Medical robotics, ReWalk, Prosthetics, Powered exoskeleton, Robotics, Ekso Bionics

ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.

Key Points: 
  • ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.
  • ReWalks mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies.
  • Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany.
  • ReWalk is a registered trademark of ReWalk Robotics Ltd. in Israel and the Unites States.